Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KB-GDT-01 |
| Synonyms | |
| Therapy Description |
KB-GDT-01 comprises donor-derived gamma delta T-lymphocytes, which potentially induce a cytotoxic T-lymphocyte (CTL) response against tumor cells (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KB-GDT-01 | Deltacel|KB-GDT 01|KB-GDT01 | KB-GDT-01 comprises donor-derived gamma delta T-lymphocytes, which potentially induce a cytotoxic T-lymphocyte (CTL) response against tumor cells (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06069570 | Phase I | KB-GDT-01 | Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC | Recruiting | USA | 0 |